Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1972 1
1976 1
1978 2
1980 1
1981 1
1982 3
1986 1
1987 1
1988 3
1989 2
1990 3
1991 5
1992 5
1993 8
1994 2
1995 3
1996 4
1997 9
1998 5
1999 12
2000 7
2001 6
2002 7
2003 4
2004 2
2005 6
2006 7
2007 2
2008 2
2009 5
2010 6
2011 3
2012 6
2013 3
2014 4
2015 4
2016 5
2017 5
2018 6
2019 7
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

163 results
Results by year

Citations

2 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
Type 1 Diabetes: an Association Between Autoimmunity, the Dynamics of Gut Amyloid-producing E. coli and Their Phages.
Tetz G, Brown SM, Hao Y, Tetz V. Tetz G, et al. Sci Rep. 2019 Jul 4;9(1):9685. doi: 10.1038/s41598-019-46087-x. Sci Rep. 2019. PMID: 31273267 Free PMC article.
The etiopathogenesis of type 1 diabetes (T1D), a common autoimmune disorder, is not completely understood. Recent studies suggested the gut microbiome plays a role in T1D. ...In children who presented seroconversion or developed T1D, we observed an increase i …
The etiopathogenesis of type 1 diabetes (T1D), a common autoimmune disorder, is not completely understood. Recent studi …
Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans.
Vatanen T, Kostic AD, d'Hennezel E, Siljander H, Franzosa EA, Yassour M, Kolde R, Vlamakis H, Arthur TD, Hämäläinen AM, Peet A, Tillmann V, Uibo R, Mokurov S, Dorshakova N, Ilonen J, Virtanen SM, Szabo SJ, Porter JA, Lähdesmäki H, Huttenhower C, Gevers D, Cullen TW, Knip M; DIABIMMUNE Study Group, Xavier RJ. Vatanen T, et al. Cell. 2016 May 5;165(4):842-53. doi: 10.1016/j.cell.2016.04.007. Epub 2016 Apr 28. Cell. 2016. PMID: 27133167 Free PMC article.
Therefore, their lipopolysaccharide (LPS) exposures arose primarily from Bacteroides rather than from Escherichia coli, which is a potent innate immune activator. We show that Bacteroides LPS is structurally distinct from Ecoli LPS and inhibits innat …
Therefore, their lipopolysaccharide (LPS) exposures arose primarily from Bacteroides rather than from Escherichia coli, which …
Seasonality and autoimmune diseases: The contribution of the four seasons to the mosaic of autoimmunity.
Watad A, Azrielant S, Bragazzi NL, Sharif K, David P, Katz I, Aljadeff G, Quaresma M, Tanay G, Adawi M, Amital H, Shoenfeld Y. Watad A, et al. J Autoimmun. 2017 Aug;82:13-30. doi: 10.1016/j.jaut.2017.06.001. Epub 2017 Jun 16. J Autoimmun. 2017. PMID: 28624334 Review.
In addition, higher Rotavirus infections during the winter precedes type 1 diabetes mellitus onset (T1DM). Moreover, Escherichia coli (Ecoli) infection prior to primary biliary cirrhosis (PBC) and T1DM disease onset subseq …
In addition, higher Rotavirus infections during the winter precedes type 1 diabetes mellitus onset (T1DM). Moreo …
Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects.
Geerlings SE, Meiland R, van Lith EC, Brouwer EC, Gaastra W, Hoepelman AI. Geerlings SE, et al. Diabetes Care. 2002 Aug;25(8):1405-9. doi: 10.2337/diacare.25.8.1405. Diabetes Care. 2002. PMID: 12145242
RESULTS: The mean numbers of type 1-fimbriated E. coli that adhered to diabetic and control cells were 12.9 and 6.1 (P = 0.001), respectively, whereas those of P-fimbriated E. coli were 8.8 and 8.1 (P = 0.8), and those of no …
RESULTS: The mean numbers of type 1-fimbriated E. coli that adhered to diabetic and control cells were 12.9 and …
Differences in the gut microbiota of healthy children and those with type 1 diabetes.
Soyucen E, Gulcan A, Aktuglu-Zeybek AC, Onal H, Kiykim E, Aydin A. Soyucen E, et al. Pediatr Int. 2014 Jun;56(3):336-43. doi: 10.1111/ped.12243. Epub 2014 Jan 29. Pediatr Int. 2014. PMID: 24475780
RESULTS: Bifidobacterium colonization was lower in patients with type 1 diabetes compared to the control group, whereas Candida albicans and Enterobacteriaceae other than Echerichia coli colonization was increased. CONCLUSION: A decrease in beneficial …
RESULTS: Bifidobacterium colonization was lower in patients with type 1 diabetes compared to the control group, whereas …
Spotlight on insulin glargine in type 1 and 2 diabetes mellitus.
McKeage K, Goa KL. McKeage K, et al. Treat Endocrinol. 2002;1(1):55-8. doi: 10.2165/00024677-200201010-00006. Treat Endocrinol. 2002. PMID: 15765621 Review.
Insulin glargine is a recombinant human insulin analog produced by DNA technology using a nonpathogenic strain of Escherichia coli. ...Insulin glargine is indicated as a once daily subcutaneous injection to provide basal glycemic control in adults and children aged …
Insulin glargine is a recombinant human insulin analog produced by DNA technology using a nonpathogenic strain of Escherichia coli
Recombinant IA-2 expressed in E. coli can be used for the routine detection of autoantibodies in Type-I diabetes.
Morgenthaler NG, Löbner K, Morgenthaler UY, Christie MR, Seissler J, Scherbaum WA. Morgenthaler NG, et al. Horm Metab Res. 1998 Sep;30(9):559-64. doi: 10.1055/s-2007-978933. Horm Metab Res. 1998. PMID: 9808324
The average yield of IA-2ic was about 1 mg purified protein from one litre of culture medium with E. coli. We could demonstrate the immunological activity of this material by blocking the autoantibody reactivity to in vitro synthesised IA-2ic. ...Sera from 46 …
The average yield of IA-2ic was about 1 mg purified protein from one litre of culture medium with E. coli. We could dem …
Insulin glargine: a review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus.
McKeage K, Goa KL. McKeage K, et al. Drugs. 2001;61(11):1599-624. doi: 10.2165/00003495-200161110-00007. Drugs. 2001. PMID: 11577797 Review.
Insulin glargine is a recombinant human insulin analogue produced by DNA technology using a nonpathogenic strain of Escherichia coli. ...Insulin glargine is indicated as a once daily subcutaneous injection to provide basal glycaemic control in adults and children ag …
Insulin glargine is a recombinant human insulin analogue produced by DNA technology using a nonpathogenic strain of Escherichia co
Oral LPS Dosing Induces Local Immunological Changes in the Pancreatic Lymph Nodes in Mice.
Kihl P, Krych L, Deng L, Kildemoes AO, Laigaard A, Hansen LH, Hansen CHF, Buschard K, Nielsen DS, Hansen AK. Kihl P, et al. J Diabetes Res. 2019 Mar 6;2019:1649279. doi: 10.1155/2019/1649279. eCollection 2019. J Diabetes Res. 2019. PMID: 30956991 Free PMC article.
Lacking the initial contact between the immune system and microbial-associated molecular patterns (MAMPs), such as lipopolysaccharides (LPS), early in life, may be regarded as one of the causal factors of the increasing global increase in the incidence of autoimmune diseases, suc …
Lacking the initial contact between the immune system and microbial-associated molecular patterns (MAMPs), such as lipopolysaccharides (LPS) …
Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
Roep BO, Atkinson MA, van Endert PM, Gottlieb PA, Wilson SB, Sachs JA. Roep BO, et al. J Autoimmun. 1999 Sep;13(2):267-82. doi: 10.1006/jaut.1999.0312. J Autoimmun. 1999. PMID: 10479395 Clinical Trial.
A T cell workshop was organized by the Immunology of Diabetes Society with the aim of appreciating and identifying problems associated with autoreactive T cell assays in type 1 diabetes. ...Moreover, autoantigens expressed in E. coli inte …
A T cell workshop was organized by the Immunology of Diabetes Society with the aim of appreciating and identifying problems associate …
163 results
Jump to page
Feedback